Abstract:BACKGROUND: Statins can block many intracellular signal transductive pathways and suppress the proliferation of various cells by affecting the synthesis of mevalonic acid and the translation following modification of some membrane-connecting proteins.OBJETCIVE: To investigate the influence of simvastatin on the proliferation of lung fibroblasts, the synthesis of collagen and the secretion of matrix metalproteinase-2 (MMP-2).DESIGN:Completely randomized controlled study.SETTING: At Organ Transplanting Research Institute of Fuwai Cardiovasular Diseases Hospital, Peking Union Medical College.MATERIALS: This study was carried out at the Laboratory of Cardiology of Beijing Union Medical College hospital, Peking Union Medical College from June 2004 to October 2004. Lung fibroblasts derived from neonatal SD rats were co-cultured in vitro with different dosage of simvastatin of 0, 1, 5, 10,50 μmol/L, and 50 μmol/L simvastatin + 200 μmol/L mevalonic acid.METHODS: Lung fibroblasts deriving from neonatal SD rat were co-cultured with different dosage of simvastatine in vitro. Methyl thiazolyl tetrazolium colorinetry was used to detect the cell proliferation, and cell immunohistochemical assay was used to determine the collagen synthesis and meanwhile,MMP-2 content in supernatant was examined with enzyme-linked immunosorbent assay.MAIN OUTCOME MEASURES: The proliferation of fibroblasts, the synthesis of collagen and the secretion of MMP-2 due to different dosage of simvastatin intervention and simvastatin combined with mevalonic acid.presenting the expression of type Ⅰ, Ⅲ of collagen in lung fibroblasts and the level of MMP-2 in 5, 10, 50 μmol/L simvastatin group were obviously lower than those of 0 μmol/L simvastatin group (0. 520 ± 0.010, 0. 334 ± 0.011,0.260±0.012, 0.111±0.011; 0.508±0.011, 0.324±0.014, 0.232±0.015, 0. 083 ±0. 015; 0.445 ±0. 017, 0. 305 ±0. 015, 0.216 ±0. 015,0.068±0.012; 0.561±0.013, 0.361 ±0.012, 0.289±0.012, 0.140value, the mean absorbency( A value) in lung fibroblasts and the level of MMP-2 in 50 μmol/L simvastatin + 200 μmol/L mevalonic acid group were obviously higher than that of the 50 μmol/L simvastatin group(0. 567±0.015, 0.354±0.014, 0.283±0.012, 0.138±0.011, t=4.715-10.950, P ＜ 0.01).CONCLUSION: Simvastatin could suppress the fibroblast proliferation and collagen synthesis, attenuate the secretion of MMP-2 and suppress consequently the adhesion and migration of lung fibroblasts; moreover, it has the capability of anti-cell proliferation by affecting the mevalonic acid pathway.

Simvastatin Inhibits the Proliferation of A549 Lung Cancer Cells Through Oxidative Stress and Up-Regulation of SOD2.

Simvastatin Protects Human Osteosarcoma Cells from Oxidative Stress-Induced Apoptosis Through Mitochondrial-Mediated Signaling

Simvastatin Inhibits Proliferation and Induces Apoptosis in Human Lung Cancer Cells.

Statins enhance anti-tumro effect of sub reoylanilide hydroxamic acid on human non-small cell lung carcinoma cells

Simvastatin induces breast cancer cell death through oxidative stress up-regulating miR-140-5p

Involvement of Oxidative Stress in Simvastatin-Induced Apoptosis of Murine CT26 Colon Carcinoma Cells

Simvastatin inhibit proliferation in vascular smooth muscle cells in association with induction of PTEN and p27

Statins Inhibit Pulmonary Artery Smooth Muscle Cell Proliferation by Upregulation of HO-1 and P21 WAF1

Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis Via AKT/mTOR, ERK and JAK2/STAT3 Pathway

Simvastatin for lung fibroblast function and its inhibitory pathway in rats

Simvastatin Inhibits Proliferation and Promotes Apoptosis of Oral Squamous Cell Carcinoma Through KLF2 Signal.

Simvastatin Induces Caspase-Dependent Apoptosis and Activates P53 in OCM-1 Cells.

Simvastatin Suppresses the Proangiogenic Microenvironment of Human Hepatic Stellate Cells Via the Kruppel-like Factor 2 Pathway.

Effects of HMG-CoA Reductase Inhibitors on Proliferation and Growth of Gastric Cancer Cells in Vitro

Simvastatin suppresses breast cancer cell proliferation induced by senescent cells

Activation of AMPK by Simvastatin Inhibited Breast Tumor Angiogenesis Via Impeding HIF-1-induced Pro-Angiogenic Factor

Simvastatin suppresses cell migration and invasion , induces G 0 / G 1 cell cycle arrest and apoptosis in osteosarcoma cells

Simvastatin induces pyroptosis via ROS/caspase-1/GSDMD pathway in colon cancer

Synergistic effect of receptor-interacting protein 140 and simvastatin on the inhibition of proliferation and survival of hepatocellular carcinoma cells

Simvastatin Induces Cell Cycle Arrest and Inhibits Proliferation of Bladder Cancer Cells Via PPARγ Signalling Pathway.

Effects of simvastatin on cell cycle progression and intracellular Ca2+ concentration of liver fat - storing cells